UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015098 |
|---|---|
| Receipt number | R000017566 |
| Scientific Title | Phase II study of S-1+CPT-11+Bevacizumab as second-line therapy in metastatic colorectal cancer which has prior therapy of S-1+L-OHP+Bevacizumab |
| Date of disclosure of the study information | 2014/09/09 |
| Last modified on | 2019/10/07 14:49:57 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/09/09 16:13:52 | ||
| 2 | Update | 2014/09/09 16:30:53 | Date of disclosure of the study information |
|
| 3 | Update | 2019/09/30 17:53:56 | UMIN ID1 |
|
| 4 | Update | 2019/10/07 14:49:57 | Recruitment status Date of IRB Last follow-up date |
